TECH5, an innovator in the field of biometrics and digital identity management, and Solem, an international technology company that integrates process and business intelligence to its services to enhance high productivity, efficiency, and continuous transformation of its customers, announced their partnership and launched a biometric-based solution that links a person to their COVID-19 test results biometrically. The solution will help trace the virus, avoid impersonation, formalize consent, and facilitate appropriate quarantining of an infected person.
The solution has been tested on the first customer in Chile and proven its efficacy for biometric traceability. It will now be implemented for the active search of COVID-19 cases. Every worker will go through a weekly digital onboarding process to collect a facial image, test result and number associated with an antigen rapid test, as well as other data. The rapid test number and test result will be linked to a person’s biometrics, and using the biometric matching technology of TECH5, T5-Face, an employer will be able to verify a worker’s identity upon arrival to the worksite.
“The solution is fully inclusive even for those workers who do not have a smartphone, as onboarding can be done in the clinic prior to testing.” – comments Víctor Parra, Solem Product manager. “The same solution can be used in cases when symptoms are suspected to make sure that the person has taken a rapid test, avoiding in this way, the entry of a person with positive virus detection into a worksite.”- says Mr. Parra.
“We are delighted to announce our partnership with Solem. For TECH5 it is a great opportunity to introduce its technologies and solutions to a wider range of customers, as well as prove its effectiveness in various use cases across Latin America.”- comments Jeremy James, TECH5 Vice President Sales for Caribbean & Latin America.
In 2022, the partners are planning to develop other biometric solutions to help stop the spread of a deadly virus.